Hayat Clinic And Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-05-2024
- Paid Up Capital ₹ 0.10 M
as on 15-05-2024
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2022
- Revenue %
(FY 2022)
- Profit 2.21%
(FY 2022)
- Ebitda
- Net Worth -159.67%
(FY 2022)
- Total Assets -5.65%
(FY 2022)
About Hayat Clinic And Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajib Saikia and Shareen Rahman serve as directors at the Company.
- CIN/LLPIN
U85320AS2019PTC019038
- Company No.
019038
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Feb 2019
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Company Details
- Location
Kamrup, Assam, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Hayat Clinic And Diagnostics?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rajib Saikia | Director | 20-Feb-2019 | Current |
Shareen Rahman | Director | 20-Feb-2019 | Current |
Financial Performance of Hayat Clinic And Diagnostics.
Hayat Clinic And Diagnostics Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 2.21% increase in profit. The company's net worth observed a substantial decline by a decrease of 159.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
What is the Ownership and Shareholding Structure of Hayat Clinic And Diagnostics?
Unlock access to Hayat Clinic And Diagnostics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Hayat Hospital Private LimitedActive 11 years 9 months
Rajib Saikia and Shareen Rahman are mutual person
- Hayat Hospital (Dibrugarh) Private LimitedActive 7 years 1 month
Rajib Saikia and Shareen Rahman are mutual person
- Shyamashree Finvest Pvt LtdActive 33 years 8 months
Rajib Saikia and Shareen Rahman are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hayat Clinic And Diagnostics?
Unlock and access historical data on people associated with Hayat Clinic And Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hayat Clinic And Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hayat Clinic And Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.